A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin
Status:
Completed
Trial end date:
1998-06-01
Target enrollment:
Participant gender:
Summary
Lifibrol is a new lipid-lowering drug which lowers cholesterol to an extent in the order of
magnitude of the statins. The mechanism of action of this compound is different from the one
of statins but remains unknown. The current study will investigate the mechanism of action
using stable-isotope turnover methods. The study will be done in healthy male volunteers.